BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22240791)

  • 1. Serum biomarker panels for the diagnosis of gastric adenocarcinoma.
    Ahn HS; Shin YS; Park PJ; Kang KN; Kim Y; Lee HJ; Yang HK; Kim CW
    Br J Cancer; 2012 Feb; 106(4):733-9. PubMed ID: 22240791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum biomarker panels for diagnosis of gastric cancer.
    Tong W; Ye F; He L; Cui L; Cui M; Hu Y; Li W; Jiang J; Zhang DY; Suo J
    Onco Targets Ther; 2016; 9():2455-63. PubMed ID: 27217769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multiplex bead array approach to identifying serum biomarkers associated with breast cancer.
    Kim BK; Lee JW; Park PJ; Shin YS; Lee WY; Lee KA; Ye S; Hyun H; Kang KN; Yeo D; Kim Y; Ohn SY; Noh DY; Kim CW
    Breast Cancer Res; 2009; 11(2):R22. PubMed ID: 19400944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer.
    Humphries JM; Penno MA; Weiland F; Klingler-Hoffmann M; Zuber A; Boussioutas A; Ernst M; Hoffmann P
    Biochim Biophys Acta; 2014 May; 1844(5):1051-8. PubMed ID: 24512919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of differentially expressed serum proteins in gastric adenocarcinoma.
    Subbannayya Y; Mir SA; Renuse S; Manda SS; Pinto SM; Puttamallesh VN; Solanki HS; Manju HC; Syed N; Sharma R; Christopher R; Vijayakumar M; Veerendra Kumar KV; Keshava Prasad TS; Ramaswamy G; Kumar RV; Chatterjee A; Pandey A; Gowda H
    J Proteomics; 2015 Sep; 127(Pt A):80-8. PubMed ID: 25952687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays.
    Yang Q; Qin J; Sun G; Qiu C; Jiang D; Ye H; Wang X; Dai L; Zhu J; Wang P; Zhang J
    Clin Transl Gastroenterol; 2020 Dec; 12(1):e00284. PubMed ID: 33346593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
    Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
    Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
    Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.
    Huang Z; Zhu D; Wu L; He M; Zhou X; Zhang L; Zhang H; Wang W; Zhu J; Cheng W; Chen Y; Fan Y; Qi L; Yin Y; Zhu W; Shu Y; Liu P
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):188-196. PubMed ID: 27756776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma.
    Boroumand-Noughabi S; Sima HR; Ghaffarzadehgan K; Jafarzadeh M; Raziee HR; Hosseinnezhad H; Moaven O; Rajabi-Mashhadi MT; Azarian AA; Mashhadinejad M; Tavakkol-Afshari J
    BMC Cancer; 2010 Jun; 10():275. PubMed ID: 20534173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum biomarker panels for the diagnosis of gastric cancer.
    Wu D; Zhang P; Ma J; Xu J; Yang L; Xu W; Que H; Chen M; Xu H
    Cancer Med; 2019 Apr; 8(4):1576-1583. PubMed ID: 30873760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive significance of preoperative serum VEGF-C and VEGF-D, independently and combined with Ca19-9, for the presence of malignancy and lymph node metastasis in patients with gastric cancer.
    Tsirlis TD; Kostakis A; Papastratis G; Masselou K; Vlachos I; Papachristodoulou A; Nikiteas NI
    J Surg Oncol; 2010 Nov; 102(6):699-703. PubMed ID: 20672317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer.
    Kasurinen A; Laitinen A; Kokkola A; Stenman UH; Böckelman C; Haglund C
    Acta Oncol; 2020 Jun; 59(6):681-688. PubMed ID: 32124669
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer.
    Huang Y; Zhu J; Li W; Zhang Z; Xiong P; Wang H; Zhang J
    Oncol Rep; 2018 Mar; 39(3):1338-1346. PubMed ID: 29286167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Label-free peptide quantification coupled with in silico mapping of proteases for identification of potential serum biomarkers in gastric adenocarcinoma patients.
    de Oliveira TM; de Lacerda JTJG; Leite GGF; Dias M; Mendes MA; Kassab P; E Silva CGS; Juliano MA; Forones NM
    Clin Biochem; 2020 May; 79():61-69. PubMed ID: 32097616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SERUM CYTOKINE OF IL-2, IL-10 AND IL-12 LEVELS IN PATIENTS WITH STOMACH ADENOCARCINOMA.
    Shokrzadeh M; Mohammadpour A; Hoseini V; Abediankenari S; Ghassemi-Barghi N; Tabari YS
    Arq Gastroenterol; 2018; 55(4):385-389. PubMed ID: 30785523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry.
    Song D; Yue L; Li H; Zhang J; Yan Z; Fan Y; Yang H; Liu Q; Zhang D; Xia Z; Qin P; Jia J; Yue M; Yu J; Zheng S; Yang F; Wang J
    Br J Cancer; 2016 Apr; 114(8):929-38. PubMed ID: 27002935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer.
    Liang Y; Wang W; Fang C; Raj SS; Hu WM; Li QW; Zhou ZW
    Oncotarget; 2016 Aug; 7(31):49565-49573. PubMed ID: 27385101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.
    Xue A; Scarlett CJ; Chung L; Butturini G; Scarpa A; Gandy R; Wilson SR; Baxter RC; Smith RC
    Br J Cancer; 2010 Jul; 103(3):391-400. PubMed ID: 20588270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Kim H; Kang KN; Shin YS; Byun Y; Han Y; Kwon W; Kim CW; Jang JY
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32492943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.